Investor News

Second quarter net sales of $7.7 billion, an increase of 11.6% Second quarter net income of $139 million, a decrease of 58.3% Second quarter Adjusted EBITDA 1 of $1.1 billion, an increase of 13.4% First six months net sales of $15.0 billion, an increase of 11.1% First six months net income of $378
August 5, 2026
NORTHFIELD, Ill., July 01, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report second quarter 2026 financial results on Wednesday, August 5, 2026. A press release and supplemental materials will be issued before the market opens.
July 1, 2026
NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are
May 27, 2026
Net sales of $7.4 billion, an increase of 10.7% Net income of $239 million, a decrease of 25.8% Adjusted EBITDA 1 of $776 million, a decrease of 10.6% Raising full year 2026 Organic Sales 2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc.
May 6, 2026
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens.
April 8, 2026